New York, New York-- (Newsfile Corp. - January 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...

Check the time stamp on this data. Updated AI-Generated Signals for Transmedics Group Inc. (TMDX) available here: TMDX. Type ...

TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion ...

Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...

View TransMedics Group, Inc. (TMDX) current and estimated P/E ratio data provided by Seeking Alpha.

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...

JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...

TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ ...

Headwaters Capital Management highlighted stocks like TransMedics Group, Inc. (NASDAQ:TMDX) in the Q4 2024 investor letter. TransMedics Group, Inc. (NASDAQ:TMDX) is a commercial-stage medical ...